• About us
  • Investment profile
  • Investment partners
  • Investment approach
  • Portfolio
  • News and views
  • Contacts
Mackintosh Capital invests in and supports small and medium enterprises (SMEs) as a catalyst for realising their potential
← Oncimmune announces intention to float

Oncimmune floats in London

Posted on May 18, 2016 by admin

Oncimmune Holdings plc, an early cancer detection technology company, saw its shares start trading on London’s AIM market today.  Oncimmune raised GBP11.0 million through the issue of shares at 130.00 pence per share. Its market capitalisation upon admission was around GBP66.3 million.

Oncimmune intends to use proceeds from the float to continue to develop its products, focused on auto-antibody tests which it said have the potential to detect cancer up to four years earlier than other methods, and can be applied to a “very wide range” of solid tumour types.  Mackintosh Capital’s partners have been investors in Oncimmune since 2012.

For more details, visit http://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/ONC/12819829.html

Mackintosh Capital LLP, Mackintosh House, 136 Newport Road, Cardiff, CF24 1DJ | Tel: +44 (0)2921 25 1455
Copyright 2010 Mackintosh Capital LLP
All rights reserved

Terms of Use and Privacy Policy